|
1
|
Na TY, Ka NL, Rhee H, Kyeong D, Kim MH,
Seong JK, Park YN and Lee MO: Interaction of hepatitis B virus X
protein with PARP1 results in inhibition of DNA repair in
hepatocellular carcinoma. Oncogene. 35:5435–5445. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Branda M and Wands JR: Signal transduction
cascades and hepatitis B and C related hepatocellular carcinoma.
Hepatology. 43:891–902. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wahid B, Ali A, Rafique S and Idrees M:
New insights into the epigenetics of hepatocellular carcinoma.
Biomed Res Int. 2017:16095752017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Cheng Q, Yin H and Yang G:
Regulation of autophagy and EMT by the interplay between p53 and
RAS during cancer progression (Review). Int J Oncol. 51:18–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Appleton K, Mackay HJ, Judson I, Plumb JA,
McCormick C, Strathdee G, Lee C, Barrett S, Reade S, Jadayel D, et
al: Phase I and pharmacodynamic trial of the DNA methyltransferase
inhibitor decitabine and carboplatin in solid tumors. J Clin Oncol.
25:4603–4609. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amato RJ: Inhibition of DNA methylation by
antisense oligonucleotide MG98 as cancer therapy. Clin Genitourin
Cancer. 5:422–426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Zhang J, Xiao X, Liu H, Wang F, Li
S, Wen Y, Wei Y, Su J and Zhang Y: The identification of
age-associated cancer markers by an integrative analysis of dynamic
DNA methylation changes. Sci Rep. 6:227222016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pfeifer GP: Defining driver DNA
methylation changes in human cancer. Int J Mol Sci. 19:E11662018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Luo D, Tian W, Li Z and Zhang X:
Demethylation of miR-495 inhibits cell proliferation, migration and
promotes apoptosis by targeting STAT-3 in breast cancer. Oncol Rep.
37:3581–3589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin DT, Xu J, Lei M, Li H, Wang Y, Liu Z,
Zhou Y and Xing M: Characterization of the novel tumor-suppressor
gene CCDC67 in papillary thyroid carcinoma. Oncotarget.
7:5830–5841. 2016.PubMed/NCBI
|
|
11
|
Park SJ, Jang HR, Kim M, Kim JH, Kwon OH,
Park JL, Noh SM, Song KS, Kim SY, Kim YH and Kim YS: Epigenetic
alteration of CCDC67 and its tumor suppressor function in gastric
cancer. Carcinogenesis. 33:1494–1501. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kamarajah SK, Frankel TL, Sonnenday C, Cho
CS and Nathan H: Critical evaluation of the american joint
commission on cancer (AJCC) 8th edition staging system for patients
with hepatocellular carcinoma (HCC): A Surveillance, Epidemiology,
End Results (SEER) analysis. J Surg Oncol. 117:644–650. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Böck J, Appenzeller S, Haertle L,
Schneider T, Gehrig A, Schröder J, Rost S, Wolf B, Bartram CR,
Sutter C and Haaf T: Single CpG hypermethylation, allele
methylation errors, and decreased expression of multiple tumor
suppressor genes in normal body cells of mutation-negative
early-onset and high-risk breast cancer patients. Int J Cancer.
143:1416–1425. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murphy GA, Spedale EJ, Powell ST, Pillus
L, Schultz SC and Chen L: The Sir4 C-terminal coiled coil is
required for telomeric and mating type silencing in saccharomyces
cerevisiae. J Mol Biol. 334:769–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tamaki H, Sanda M, Katsumata O, Hara Y,
Fukaya M and Sakagami H: Pilt is a coiled-coil domain-containing
protein that localizes at the trans-Golgi complex and regulates its
structure. FEBS Lett. 586:3064–3070. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burkhard P, Stetefeld J and Strelkov SV:
Coiled coils: A highly versatile protein folding motif. Trends Cell
Biol. 11:82–88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng JD, Zhang N, Zhao GJ, Xu LX, Yang Y,
Xu XY, Chen MK, Wang HY, Zheng SX and Li XX: MT1G is silenced by
DNA methylation and contributes to the pathogenesis of
hepatocellular carcinoma. J Cancer. 9:2807–2816. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kishino T, Niwa T, Yamashita S, Takahashi
T, Nakazato H, Nakajima T, Igaki H, Tachimori Y, Suzuki Y and
Ushijima T: Integrated analysis of DNA methylation and mutations in
esophageal squamous cell carcinoma. Mol Carcinog. 55:2077–2088.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kwon H, Song K, Han C, Zhang J, Lu L, Chen
W and Wu T: Epigenetic silencing of miRNA-34a in human
cholangiocarcinoma via EZH2 and DNA methylation Impact on
Regulation of Notch Pathway. Am J Pathol. 187:2288–2299. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alipour M, Zargar SJ, Safarian S,
Fouladdel S, Azizi E and Jafargholizadeh N: The study of DNA
methylation of bax gene promoter in breast and colorectal carcinoma
cell lines. Iran J Cancer Prev. 6:59–64. 2013.PubMed/NCBI
|
|
21
|
Lu Y, Zabihula B, Yibulayin W and Liu X:
Methylation and expression of RECK, P53 and RUNX genes in patients
with esophageal cancer. Oncol Lett. 14:5293–5298. 2017.PubMed/NCBI
|
|
22
|
Zheng J, Mei Y, Xiang P, Zhai G, Zhao N,
Xu C, Liu M, Pan Z, Tang K and Jia D: DNA methylation affects
metastasis of renal cancer and is associated with TGF-β/RUNX3
inhibition. Cancer Cell Int. 18:562018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song L, Yu H and Li Y: Diagnosis of lung
cancer by SHOX2 gene methylation assay. Mol Diagn Ther. 19:159–167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sajadian SO, Ehnert S, Vakilian H,
Koutsouraki E, Damm G, Seehofer D, Thasler W, Dooley S, Baharvand
H, Sipos B and Nussler AK: Induction of active demethylation and
5hmC formation by 5-azacytidine is TET2 dependent and suggests new
treatment strategies against hepatocellular carcinoma. Clin
Epigenetics. 7:982015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zahnow CA, Topper M, Stone M,
Murray-Stewart T, Li H, Baylin SB and Casero RA Jr: Inhibitors of
DNA methylation, histone deacetylation, and histone demethylation:
A perfect combination for cancer therapy. Adv Cancer Res.
130:55–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
